StockNews.com Begins Coverage on iCAD (NASDAQ:ICAD)

Equities research analysts at StockNews.com began coverage on shares of iCAD (NASDAQ:ICAD) in a research note issued on Monday. The brokerage set a “sell” rating on the technology company’s stock.

A number of other equities research analysts have also recently weighed in on the company. Craig Hallum cut iCAD from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 16th. Laidlaw reissued a “hold” rating on shares of iCAD in a report on Thursday, April 17th. Finally, BTIG Research cut iCAD from a “buy” rating to a “neutral” rating in a report on Wednesday, April 16th.

iCAD Stock Performance

Shares of NASDAQ ICAD opened at $3.93 on Monday. iCAD has a 1 year low of $1.18 and a 1 year high of $3.97. The firm has a market cap of $107.86 million, a price-to-earnings ratio of -30.23 and a beta of 1.35. The stock’s 50-day simple moving average is $2.55 and its 200-day simple moving average is $2.34.

iCAD (NASDAQ:ICAD) last posted its quarterly earnings results on Tuesday, May 13th. The technology company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.04. iCAD had a negative return on equity of 15.65% and a negative net margin of 17.81%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ICAD. waypoint wealth counsel grew its position in iCAD by 44.0% during the 4th quarter. waypoint wealth counsel now owns 14,400 shares of the technology company’s stock worth $26,000 after purchasing an additional 4,400 shares in the last quarter. Thompson Davis & CO. Inc. purchased a new position in iCAD during the 4th quarter worth approximately $31,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in iCAD during the 1st quarter worth approximately $40,000. PKS Advisory Services LLC purchased a new position in iCAD during the 4th quarter worth approximately $53,000. Finally, Wells Fargo & Company MN grew its position in iCAD by 51.3% during the 4th quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company’s stock worth $72,000 after purchasing an additional 13,402 shares in the last quarter. Institutional investors own 24.61% of the company’s stock.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.